06 Apr2014
Permissions for clinical trials delayed, bio pharma firms plan to leave country
There have been an approximate 17,669 suspect measles cases reported from January 1 to February 22.
With more than a year’s delay in getting permission for starting Phase 3 of the rotavirus vaccine trial among 7,000 infants, Serum Institute of India is in no mood to ask for the government’s approval for testing other vaccines in clinical trials “Be it dengue or meningitis vaccine, we are now moving out to other countries in Asia,” said Adar Poonawalla, executive director at Serum Institute of India.
